| mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.9 |
| mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |